June 2014
British Journal of School Nursing;Jun2014, Vol. 9 Issue 5, p222
Academic Journal
The article offers information on the medical condition called psoriasis. Topics discussed include the physical symptoms and causes of psoriasis, the different types of psoriasis, and recommended treatments. It cites several topical treatments for the skin disease such as Calcipotriol vitamin D, Aquamax emollient, and Salicylic acid paste. The article mentions that Psoriasis in young people can be caused by infection, skin trauma, and smoking.


Related Articles

  • Fusion protein denileukin diftitox clears psoriasis. Kuznar, Wayne // Dermatology Times;Oct2001, Vol. 22 Issue 10, p18 

    Reports the effectiveness of dermatologic agents denileukin diftitox in clearing skin lesions in patients with psoriasis vulgaris in New York. Antipsoriatic activity of denileukin; Daily dosage administration; Decrease of lesional T-cells in the dermis.

  • DERMATOLOGICAL DISORDERS.  // MPR - Physician Assistants' Edition;Winter2013/2014, Vol. 20 Issue 4, p50 

    The article offers information on various drugs for the treatment of dermatological disorders including acne, pruritus and dry skin, and psoriasis. The drugs mentioned include Amnesteem from Mylan, Enbrel from Amgen, and Dovonex Cream from LEO Pharma. Furthermore, the indications, precautions,...

  • Clobetasol foam, calcipotriene ointment a superb combination, study shows. Guttman, Cheryl // Dermatology Times;Sep2004 Supplement, Vol. 25, pS12 

    Reports on the efficacy of a combination of clobetasol foam and calcipotriene ointment for the initial clearing of localized plaque-type psoriasis. Statement of Mark Lebwohl, chairman of the department of dermatology in Mt. Sinai School of Medicine, on the medical breakthrough; Analysis of the...

  • For optimal result, begin treating with biologic while tapering conventional systemic therapy. Hill, Suzette // Dermatology Times;Sep2004 Supplement, Vol. 25, pS17 

    Discusses the safety and efficacy of biologics as first-line treatment option for psoriatic patients. Changes made to the doses of conventional systematic therapies; Affirmation that biologics also present an option for incremental improvements in patients from traditional therapies; Explanation...

  • Amevive Has Excellent Dose Response/Side-Effect Profile.  // Biotech Business;Jul99, Vol. 12 Issue 7, p1 

    Reports the result of the controlled trial of AMEVIVE, a recombinantly Engineered LFA-3/IgG1 Human Fusion Protein of Biogen Inc., in patients with moderate-to-severe chronic plaque psoriasis. Measurement of disease severity by Physician Global Assessment and the Psoriasis Activity and Severity...

  • Offering the best treatment. Jesitus, John // Dermatology Times;Feb2008, Vol. 29 Issue 2, p1 

    The article reports on the benefits from combination therapies for medical and cosmetic concerns. According to Philip Werschler, assistant clinical professor at University of Washington in Seattle, combination therapy represents the nonsurgical approach to cosmetic work. It cites that acne,...

  • 'Pre-biologics' not necessarily prehistoric. Levine, Norman // Dermatology Times;Jun2005, Vol. 26 Issue 6, p4 

    The article focuses on "pre-biologic" therapies of psoriasis. Methotrexate has been used for more than 40 years for psoriasis and psoriatic arthritis and remains the gold standard against which all other treatments are measured. Cyclosporine is one of the most effective and rapidly acting drugs...

  • Aquamol 'improves' psoriasis, finds patient survey.  // British Journal of Community Nursing;Dec2012, Vol. 17 Issue 12, p645 

    The article discusses a survey conducted on people with psoriasis in affiliation with the Psoriasis Association which showed positive results for T&R Derma's clinically proven emollient cream - Aquamol for psoriasis treatment.

  • Psoriasis: exploring the associated clinical issues and how to support your patients. VAN ONSELEN, JULIE // Journal of Aesthetic Nursing;Apr2013, Vol. 2 Issue 3, p112 

    Although psoriasis is a common condition manifesting in the skin and joints, recent clinical evidence has shown health professionals that it is a systemic disease that is more than skin deep. The most recent guidelines from the National Institute for Health and Clinical Excellence (2012) on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics